Mitsubishi UFJ Asset Management Co. Ltd. Trims Stock Holdings in UiPath, Inc. $PATH

Mitsubishi UFJ Asset Management Co. Ltd. lowered its position in shares of UiPath, Inc. (NYSE:PATH) by 4.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 79,126 shares of the company’s stock after selling 3,745 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in UiPath were worth $1,013,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. AdvisorNet Financial Inc increased its stake in shares of UiPath by 320.4% in the 2nd quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company’s stock worth $32,000 after acquiring an additional 1,887 shares in the last quarter. GAMMA Investing LLC grew its holdings in UiPath by 48.0% in the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock worth $38,000 after purchasing an additional 969 shares during the period. IFP Advisors Inc increased its stake in shares of UiPath by 508.0% during the second quarter. IFP Advisors Inc now owns 3,283 shares of the company’s stock valued at $42,000 after purchasing an additional 2,743 shares in the last quarter. Brooklyn Investment Group increased its stake in shares of UiPath by 314.3% during the first quarter. Brooklyn Investment Group now owns 4,508 shares of the company’s stock valued at $46,000 after purchasing an additional 3,420 shares in the last quarter. Finally, Bayforest Capital Ltd lifted its holdings in shares of UiPath by 852.4% during the second quarter. Bayforest Capital Ltd now owns 4,143 shares of the company’s stock valued at $53,000 after purchasing an additional 3,708 shares during the last quarter. Institutional investors own 62.50% of the company’s stock.

UiPath Price Performance

Shares of NYSE:PATH opened at $14.03 on Friday. UiPath, Inc. has a 1 year low of $9.38 and a 1 year high of $18.74. The company has a market cap of $7.45 billion, a P/E ratio of 467.70, a PEG ratio of 5.21 and a beta of 1.09. The stock’s fifty day moving average price is $14.23 and its 200-day moving average price is $12.87.

UiPath (NYSE:PATH) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.08 by $0.07. The company had revenue of $361.73 million during the quarter, compared to the consensus estimate of $347.36 million. UiPath had a return on equity of 1.28% and a net margin of 1.35%.UiPath’s revenue for the quarter was up 14.6% on a year-over-year basis. During the same period last year, the company earned $0.04 EPS. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, sell-side analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current year.

Insider Activity at UiPath

In other UiPath news, CFO Ashim Gupta sold 240,874 shares of UiPath stock in a transaction that occurred on Thursday, October 9th. The shares were sold at an average price of $17.28, for a total value of $4,162,302.72. Following the completion of the sale, the chief financial officer owned 696,117 shares of the company’s stock, valued at approximately $12,028,901.76. The trade was a 25.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Daniel Dines sold 122,734 shares of the business’s stock in a transaction on Wednesday, October 8th. The shares were sold at an average price of $14.89, for a total transaction of $1,827,509.26. Following the sale, the chief executive officer owned 613,670 shares of the company’s stock, valued at approximately $9,137,546.30. This represents a 16.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 2,319,002 shares of company stock valued at $34,094,875 over the last three months. 23.19% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

PATH has been the topic of several recent research reports. Weiss Ratings restated a “sell (d+)” rating on shares of UiPath in a research note on Thursday, October 30th. Wall Street Zen raised UiPath from a “buy” rating to a “strong-buy” rating in a report on Saturday. Canaccord Genuity Group reduced their price target on UiPath from $16.00 to $15.00 and set a “buy” rating for the company in a report on Monday, September 8th. Cowen reaffirmed a “hold” rating on shares of UiPath in a research report on Friday, September 5th. Finally, Truist Financial dropped their price target on shares of UiPath from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, September 5th. Two investment analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $13.71.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.